Melissa Epperly – Biography
Last update: March 3, 2026Executive profile
Melissa was Chief Financial Officer at Akamis Bio, and Chief Financial Officer and Head of Business Development and Operations at R-Pharm US. Melissa Epperly joined Nautilus Biotechnology in 2025.
Melissa Epperly is currentlyChief Financial Officer at Tenpoint Therapeutics - View - Tenpoint Therapeutics org chart
Director at Nautilus Biotechnology - View - Nautilus Biotechnology org chart
Director at Roivant Sciences - View - Roivant Sciences org chart
Create your alert
to follow the career of Melissa Epperly.
Education
In 2005, Melissa Epperly completed a Master of Business Administration at Harvard Business School.
They have also studied at Harvard Business School :
Find more alumni from Harvard Business School
More about Melissa Epperly
Selected links
Do you need to know more about Melissa Epperly? More results.
Participate
Social media
- Melissa Epperly on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Melissa Epperly
The colleagues of Melissa Epperly
Company Colleagues
- At Tenpoint Therapeutics, Melissa Epperly has 31 colleagues including Henric Bjarke (CEO), Carmine Circelli (Director)…
- At Nautilus Biotechnology, Melissa Epperly has 21 colleagues including Sujal Patel (CEO & Director), Farzad Nazem (Director)…
- At Roivant Sciences, Melissa Epperly has 207 colleagues including Matthew Gline (CEO), James Momtazee (Director)…
Industry Colleagues
- In the Biotechnology industry, Melissa Epperly has 35,757 colleagues in 2,406 companies located in 42 countries. 16,893 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Melissa Epperly.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Melissa Epperly.
